Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Akihiko Okuda is active.

Publication


Featured researches published by Akihiko Okuda.


PLOS Genetics | 2016

A Comprehensive Genomic Analysis Reveals the Genetic Landscape of Mitochondrial Respiratory Chain Complex Deficiencies

Masakazu Kohda; Yoshimi Tokuzawa; Yoshihito Kishita; Hiromi Nyuzuki; Yohsuke Moriyama; Yosuke Mizuno; Tomoko Hirata; Yukiko Yatsuka; Yzumi Yamashita-Sugahara; Yutaka Nakachi; Hidemasa Kato; Akihiko Okuda; Shunsuke Tamaru; Nurun Nahar Borna; Kengo Banshoya; Toshiro Aigaki; Yukiko Sato-Miyata; Kohei Ohnuma; Tsutomu Suzuki; Asuteka Nagao; Hazuki Maehata; Fumihiko Matsuda; Koichiro Higasa; Masao Nagasaki; Jun Yasuda; Masayuki Yamamoto; Takuya Fushimi; Masaru Shimura; Keiko Kaiho-Ichimoto; Hiroko Harashima

Mitochondrial disorders have the highest incidence among congenital metabolic disorders characterized by biochemical respiratory chain complex deficiencies. It occurs at a rate of 1 in 5,000 births, and has phenotypic and genetic heterogeneity. Mutations in about 1,500 nuclear encoded mitochondrial proteins may cause mitochondrial dysfunction of energy production and mitochondrial disorders. More than 250 genes that cause mitochondrial disorders have been reported to date. However exact genetic diagnosis for patients still remained largely unknown. To reveal this heterogeneity, we performed comprehensive genomic analyses for 142 patients with childhood-onset mitochondrial respiratory chain complex deficiencies. The approach includes whole mtDNA and exome analyses using high-throughput sequencing, and chromosomal aberration analyses using high-density oligonucleotide arrays. We identified 37 novel mutations in known mitochondrial disease genes and 3 mitochondria-related genes (MRPS23, QRSL1, and PNPLA4) as novel causative genes. We also identified 2 genes known to cause monogenic diseases (MECP2 and TNNI3) and 3 chromosomal aberrations (6q24.3-q25.1, 17p12, and 22q11.21) as causes in this cohort. Our approaches enhance the ability to identify pathogenic gene mutations in patients with biochemically defined mitochondrial respiratory chain complex deficiencies in clinical settings. They also underscore clinical and genetic heterogeneity and will improve patient care of this complex disorder.


Cell Stem Cell | 2011

Indefinite Self-Renewal of ESCs through Myc/Max Transcriptional Complex-Independent Mechanisms

Tomoaki Hishida; Yuriko Nozaki; Yutaka Nakachi; Yosuke Mizuno; Yasushi Okazaki; Masatsugu Ema; Satoru Takahashi; Masazumi Nishimoto; Akihiko Okuda

Embryonic stem cells (ESCs) can self-renew indefinitely under the governance of ESC-specific transcriptional circuitries in which each transcriptional factor regulates distinct or overlapping sets of genes with other factors. c-Myc is a key player that is crucially involved in maintaining the undifferentiated state and the self-renewal of ESCs. However, the mechanism by which c-Myc helps preserve the ESC status is still poorly understood. Here we addressed this question by performing loss-of-function studies with the Max gene, which encodes the best-characterized partner protein for all Myc family proteins. Although Myc/Max complexes are widely regarded as crucial regulators of the ESC status, our data revealed that ESCs do not absolutely require these complexes in certain contexts and that this requirement is restricted to empirical ESC culture conditions without a MAPK inhibitor.


Nature Communications | 2013

Max is a repressor of germ cell-related gene expression in mouse embryonic stem cells

Ikuma Maeda; Daiji Okamura; Yuko Tokitake; Makiko Ikeda; Hiroko Kawaguchi; Nathan Mise; Kuniya Abe; Toshiaki Noce; Akihiko Okuda; Yasuhisa Matsui

Embryonic stem cells and primordial germ cells (PGCs) express many pluripotency-associated genes, but embryonic stem cells do not normally undergo conversion into primordial germ cells. Thus, we predicted that there is a mechanism that represses primordial germ cell-related gene expression in embryonic stem cells. Here we identify genes involved in this putative mechanism, by using an embryonic stem cell line with a Vasa reporter in an RNA interference screen of transcription factor genes expressed in embryonic stem cells. We identify five genes that result in the expression of Vasa when silenced. Of these, Max is the most striking. Transcriptome analysis reveals that Max knockdown in embryonic stem cells results in selective, global derepression of germ cell-specific genes. Max interacts with histone H3K9 methyltransferases and associates with the germ cell-specific genes in embryonic stem cells. In addition, Max knockdown results in a decrease in histone H3K9 dimethylation at their promoter regions. We propose that Max is part of protein complex that acts as a repressor of germ cell-related genes in embryonic stem cells.


Proceedings of the National Academy of Sciences of the United States of America | 2013

Transcription factors interfering with dedifferentiation induce cell type-specific transcriptional profiles

Takafusa Hikichi; Ryo Matoba; Takashi Ikeda; Akira Watanabe; Takuya Yamamoto; Satoko Yoshitake; Miwa Tamura-Nakano; Takayuki Kimura; Masayoshi Kamon; Mari Shimura; Koichi Kawakami; Akihiko Okuda; Hitoshi Okochi; Takafumi Inoue; Atsushi Suzuki; Shinji Masui

Transcription factors (TFs) are able to regulate differentiation-related processes, including dedifferentiation and direct conversion, through the regulation of cell type-specific transcriptional profiles. However, the functional interactions between the TFs regulating different transcriptional profiles are not well understood. Here, we show that the TFs capable of inducing cell type-specific transcriptional profiles prevent the dedifferentiation induced by TFs for pluripotency. Of the large number of TFs expressed in a neural-lineage cell line, we identified a subset of TFs that, when overexpressed, strongly interfered with the dedifferentiation triggered by the procedure to generate induced pluripotent stem cells. This interference occurred through a maintenance mechanism of the cell type-specific transcriptional profile. Strikingly, the maintenance activity of the interfering TF set was strong enough to induce the cell line-specific transcriptional profile when overexpressed in a heterologous cell type. In addition, the TFs that interfered with dedifferentiation in hepatic-lineage cells involved TFs with known induction activity for hepatic-lineage cells. Our results suggest that dedifferentiation suppresses a cell type-specific transcriptional profile, which is primarily maintained by a small subset of TFs capable of inducing direct conversion. We anticipate that this functional correlation might be applicable in various cell types and might facilitate the identification of TFs with induction activity in efforts to understand differentiation.


Nucleic Acids Research | 2012

Emx2 is a dose-dependent negative regulator of Sox2 telencephalic enhancers

Jessica Mariani; R. Favaro; C. Lancini; Giulia Vaccari; A. L. Ferri; J. Bertolini; D. Tonoli; E. Latorre; R. Caccia; Antonella Ronchi; S. Ottolenghi; Satoru Miyagi; Akihiko Okuda; Vincenzo Zappavigna; Silvia K. Nicolis

The transcription factor Sox2 is essential for neural stem cells (NSC) maintenance in the hippocampus and in vitro. The transcription factor Emx2 is also critical for hippocampal development and NSC self-renewal. Searching for ‘modifier’ genes affecting the Sox2 deficiency phenotype in mouse, we observed that loss of one Emx2 allele substantially increased the telencephalic β-geo (LacZ) expression of a transgene driven by the 5′ or 3′ Sox2 enhancer. Reciprocally, Emx2 overexpression in NSC cultures inhibited the activity of the same transgene. In vivo, loss of one Emx2 allele increased Sox2 levels in the medial telencephalic wall, including the hippocampal primordium. In hypomorphic Sox2 mutants, retaining a single ‘weak’ Sox2 allele, Emx2 deficiency substantially rescued hippocampal radial glia stem cells and neurogenesis, indicating that Emx2 functionally interacts with Sox2 at the stem cell level. Electrophoresis mobility shift assays and transfection indicated that Emx2 represses the activities of both Sox2 enhancers. Emx2 bound to overlapping Emx2/POU-binding sites, preventing binding of the POU transcriptional activator Brn2. Additionally, Emx2 directly interacted with Brn2 without binding to DNA. These data imply that Emx2 may perform part of its functions by negatively modulating Sox2 in specific brain areas, thus controlling important aspects of NSC function in development.


Stem Cells | 2012

Sirt1, p53, and p38MAPK Are Crucial Regulators of Detrimental Phenotypes of Embryonic Stem Cells with Max Expression Ablation†‡§

Tomoaki Hishida; Yuriko Nozaki; Yutaka Nakachi; Yosuke Mizuno; Hiroyoshi Iseki; Miyuki Katano; Masayoshi Kamon; Masataka Hirasaki; Masazumi Nishimoto; Yasushi Okazaki; Akihiko Okuda

c‐Myc participates in diverse cellular processes including cell cycle control, tumorigenic transformation, and reprogramming of somatic cells to induced pluripotent cells. c‐Myc is also an important regulator of self‐renewal and pluripotency of embryonic stem cells (ESCs). We recently demonstrated that loss of the Max gene, encoding the best characterized partner for all Myc family proteins, causes loss of the pluripotent state and extensive cell death in ESCs strictly in this order. However, the mechanisms and molecules that are responsible for these phenotypes remain largely obscure. Here, we show that Sirt1, p53, and p38MAPK are crucially involved in the detrimental phenotype of Max‐null ESCs. Moreover, our analyses revealed that these proteins are involved at varying levels to one another in the hierarchy of the pathway leading to cell death in Max‐null ESCs. STEM CELLS2012;30:1634–1644


PLOS ONE | 2013

In Vivo Function and Evolution of the Eutherian-Specific Pluripotency Marker UTF1

Masazumi Nishimoto; Miyuki Katano; Toshiyuki Yamagishi; Tomoaki Hishida; Masayoshi Kamon; Ayumu Suzuki; Masataka Hirasaki; Yoko Nabeshima; Yo-ichi Nabeshima; Yukako Katsura; Yoko Satta; Janine E. Deakin; Jennifer A. Marshall Graves; Yoko Kuroki; Ryuichi Ono; Fumitoshi Ishino; Masatsugu Ema; Satoru Takahashi; Hidemasa Kato; Akihiko Okuda

Embryogenesis in placental mammals is sustained by exquisite interplay between the embryo proper and placenta. UTF1 is a developmentally regulated gene expressed in both cell lineages. Here, we analyzed the consequence of loss of the UTF1 gene during mouse development. We found that homozygous UTF1 mutant newborn mice were significantly smaller than wild-type or heterozygous mutant mice, suggesting that placental insufficiency caused by the loss of UTF1 expression in extra-embryonic ectodermal cells at least in part contributed to this phenotype. We also found that the effects of loss of UTF1 expression in embryonic stem cells on their pluripotency were very subtle. Genome structure and sequence comparisons revealed that the UTF1 gene exists only in placental mammals. Our analyses of a family of genes with homology to UTF1 revealed a possible mechanism by which placental mammals have evolved the UTF1 genes.


Stem Cells | 2016

Combined Overexpression of JARID2, PRDM14, ESRRB, and SALL4A Dramatically Improves Efficiency and Kinetics of Reprogramming to Induced Pluripotent Stem Cells

Hiroyoshi Iseki; Yutaka Nakachi; Tomoaki Hishida; Yzumi Yamashita-Sugahara; Masataka Hirasaki; Atsushi Ueda; Yoko Tanimoto; Saori Iijima; Fumihiro Sugiyama; Ken-ichi Yagami; Satoru Takahashi; Akihiko Okuda; Yasushi Okazaki

Identification of a gene set capable of driving rapid and proper reprogramming to induced pluripotent stem cells (iPSCs) is an important issue. Here we show that the efficiency and kinetics of iPSC reprogramming are dramatically improved by the combined expression of Jarid2 and genes encoding its associated proteins. We demonstrate that forced expression of JARID2 promotes iPSC reprogramming by suppressing the expression of Arf, a known reprogramming barrier, and that the N‐terminal half of JARID2 is sufficient for such promotion. Moreover, JARID2 accelerated silencing of the retroviral Klf4 transgene and demethylation of the Nanog promoter, underpinning the potentiating activity of JARID2 in iPSC reprogramming. We further show that JARID2 physically interacts with ESRRB, SALL4A, and PRDM14, and that these JARID2‐associated proteins synergistically and robustly facilitate iPSC reprogramming in a JARID2‐dependent manner. Our findings provide an insight into the important roles of JARID2 during reprogramming and suggest that the JARID2‐associated protein network contributes to overcoming reprogramming barriers. Stem Cells 2016;34:322–333


Stem Cells and Development | 2014

Identification of Ccr4-Not Complex Components as Regulators of Transition from Partial to Genuine Induced Pluripotent Stem Cells

Masayoshi Kamon; Miyuki Katano; Keiko Hiraki-Kamon; Tomoaki Hishida; Yutaka Nakachi; Yosuke Mizuno; Yasushi Okazaki; Ayumu Suzuki; Masataka Hirasaki; Atsushi Ueda; Masazumi Nishimoto; Hidemasa Kato; Akihiko Okuda

Somatic cells can be reprogrammed to induced pluripotent stem cells (iPSCs) by defined factors. However, substantial cell numbers subjected to iPSC induction stray from the main reprogramming route and are immortalized as partial iPSCs. These partial iPSCs can become genuine iPSCs by exposure to the ground state condition. However, such conversion is only possible for mouse partial iPSCs, and it is not applicable to human cells. Moreover, the molecular basis of this conversion is completely unknown. Therefore, we performed genome-wide screening with a piggyBac vector to identify genes involved in conversion from partial to genuine iPSCs. This screening led to identification of Cnot2, one of the core components of the Ccr4-Not complex. Subsequent analyses revealed that other core components, Cnot1 and Cnot3, also contributed to the conversion. Thus, our data have uncovered a novel role of core components of the Ccr4-Not complex as regulators of transition from partial to genuine iPSCs.


PLOS ONE | 2013

Striking Similarity in the Gene Expression Levels of Individual Myc Module Members among ESCs, EpiSCs, and Partial iPSCs

Masataka Hirasaki; Keiko Hiraki-Kamon; Masayoshi Kamon; Ayumu Suzuki; Miyuki Katano; Masazumi Nishimoto; Akihiko Okuda

Predominant transcriptional subnetworks called Core, Myc, and PRC modules have been shown to participate in preservation of the pluripotency and self-renewality of embryonic stem cells (ESCs). Epiblast stem cells (EpiSCs) are another cell type that possesses pluripotency and self-renewality. However, the roles of these modules in EpiSCs have not been systematically examined to date. Here, we compared the average expression levels of Core, Myc, and PRC module genes between ESCs and EpiSCs. EpiSCs showed substantially higher and lower expression levels of PRC and Core module genes, respectively, compared with those in ESCs, while Myc module members showed almost equivalent levels of average gene expression. Subsequent analyses revealed that the similarity in gene expression levels of the Myc module between these two cell types was not just overall, but striking similarities were evident even when comparing the expression of individual genes. We also observed equivalent levels of similarity in the expression of individual Myc module genes between induced pluripotent stem cells (iPSCs) and partial iPSCs that are an unwanted byproduct generated during iPSC induction. Moreover, our data demonstrate that partial iPSCs depend on a high level of c-Myc expression for their self-renewal properties.

Collaboration


Dive into the Akihiko Okuda's collaboration.

Top Co-Authors

Avatar

Tomoaki Hishida

Salk Institute for Biological Studies

View shared research outputs
Top Co-Authors

Avatar

Masataka Hirasaki

Saitama Medical University

View shared research outputs
Top Co-Authors

Avatar

Masayoshi Kamon

Saitama Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Miyuki Katano

Saitama Medical University

View shared research outputs
Top Co-Authors

Avatar

Yasushi Okazaki

Saitama Medical University

View shared research outputs
Top Co-Authors

Avatar

Yutaka Nakachi

Saitama Medical University

View shared research outputs
Top Co-Authors

Avatar

Yosuke Mizuno

Tokyo Institute of Technology

View shared research outputs
Top Co-Authors

Avatar

Ayumu Suzuki

Saitama Medical University

View shared research outputs
Top Co-Authors

Avatar

Hidemasa Kato

Saitama Medical University

View shared research outputs
Researchain Logo
Decentralizing Knowledge